Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer
Clinical trial NCT02007005 · COMPLETED
Trial details
- NCT number
- NCT02007005
- Sponsor
- Abnoba Gmbh
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2012-02-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.